Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.
Cardiovascular disease (CVD) is the major cause of morbidity and mortality in diabetes. To determine the proportion of patients who met the American Diabetes Association guidelines for control of CVD risk factors and to assess the achievement of these guidelines in women compared with men, we conducted a cross-sectional study of 3678 diabetic cohorts followed at seven medical centers, two Veteran Administration hospitals, three urban clinics, and two suburban clinics. Overall, 28% met the target blood pressure of <130/80 mm Hg, 48.8% achieved a goal low-density lipoprotein cholesterol of <100 mg/dL, and 35.8% had hemoglobin A1c of <7%. Gender comparisons of 2788 diabetic patients at urban and suburban centers showed that women had a lower percentage of low-density lipoprotein cholesterol <100 mg/dL (45.8 vs. 51.3, p<0.01) and a lower percentage of screening for retinopathy (54 vs. 60, p<0.01) and nephropathy (37 vs. 49, p<0.01). However, overall there were no gender differences in the percentage of patients who achieved a goal blood pressure <130/80 mm Hg or hemoglobin A1c <7%. Control of blood pressure and other CVD risk factors in diabetic patients was largely suboptimal, especially for diabetic women. These observations underscore the need for better strategies for control of CVD risk in the diabetic population in general, and women in particular.
McFarlane
Samy I
SI
SUNY-Downstate Medical Center, 450 Clarkson Avenue, Box 50, Brooklyn, NY 11203, USA. smcfarlane@downstate.edu
Castro
Jonathan
J
Kaur
Jasjeet
J
Shin
John J
JJ
Kelling
Douglas
D
Farag
Amal
A
Simon
Nicole
N
El-Atat
Fadi
F
Sacerdote
Alan
A
Basta
Emad
E
Flack
John
J
Bakris
George
G
Sowers
James R
JR
D000368:Aged; D002318:Cardiovascular Diseases / Q000503:physiopathology / Q000517:prevention & control*; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000503:physiopathology*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006949:Hyperlipidemias / Q000503:physiopathology / Q000517:prevention & control; D006973:Hypertension / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D009765:Obesity / Q000503:physiopathology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D016896:Treatment Outcome; D014932:Women's Health Services / Q000592:standards*
D006442:Glycated Hemoglobin
Diabetes Care. 2003 Jan;26 Suppl 1:S87-8
12502626
Circulation. 1999 Sep 7;100(10):1134-46
10477542
JAMA. 1999 Jun 2;281(21):2005-12
10359389
Diabetes Care. 1997;20 Suppl 1:S1-70
9028710
Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):491-7
10423075
Scand Cardiovasc J. 2003;37(1):3-12
12745796
Diabetes Care. 1998 Aug;21(8):1258-65
9702430
JAMA. 2001 May 16;285(19):2486-97
11368702
Lancet. 1998 Sep 12;352(9131):832-3
9742972
Lancet. 2001 Mar 24;357(9260):905-10
11289345
Diabetes Care. 2002 Apr;25(4):718-23
11919131
Arch Intern Med. 2003 Jul 28;163(14):1735-40
12885690
JAMA. 1995 Nov 8;274(18):1436-44
7474189
N Engl J Med. 1998 Dec 31;339(27):1957-63
9869666
Diabetes Care. 2000 Jun;23(6):754-8
10840991
Diabetes Care. 2003 Jan;26(1):16-23
12502653
Circulation. 2004 Jul 13;110(2):227-39
15249516
Circulation. 1998 Dec 8;98(23):2513-9
9843456
Lancet. 1998 Jun 13;351(9118):1755-62
9635947
Lancet. 1998 Sep 12;352(9131):837-53
9742976
Med Clin (Barc). 2003 Apr 5;120(12):446-50
12689550
JAMA. 2004 Jan 21;291(3):335-42
14734596
Pharmacotherapy. 2003 May;23(5):659-65
12741441
N Engl J Med. 1998 Jul 23;339(4):229-34
9673301
J Clin Endocrinol Metab. 2001 Feb;86(2):713-8
11158035
Diabetes Care. 1997 Apr;20(4):614-20
9096989
Curr Diab Rep. 2003 Jun;3(3):223-9
12762970
Diabet Med. 2000 May;17(5):335
10872530
JAMA. 2003 May 21;289(19):2560-72
12748199
Diabetes Metab. 2003 Apr;29(2 Pt 1):152-8
12746636
Arch Intern Med. 1999 Dec 13-27;159(22):2661-7
10597756
Diabetes Care. 2003 Mar;26(3):563-8
12610002
JAMA. 2002 May 15;287(19):2563-9
12020338
N Engl J Med. 2001 Apr 12;344(15):1168; author reply 1169-70
11302146
JAMA. 1999 Apr 14;281(14):1291-7
10208144
J Clin Hypertens (Greenwich). 2004 Jan;6(1):18-25
14724420
JAMA. 1998 May 27;279(20):1615-22
9613910
BMJ. 1998 Sep 12;317(7160):703-13
9732337
Arch Intern Med. 2001 Jul 23;161(14):1717-23
11485504
Arch Intern Med. 1998 Mar 23;158(6):617-21
9521226